4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095021
Director acquired 500 shares (grant or award)
- Director acquired 321,150 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Pamukcu Rifat · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-23 | Conversion : show line 1 in the form | +49,280 | 57,142 | D |
| 2023-08-23 | Grant or award : show line 2 in the form | +500 | 3,356 | D |
| 2022-08-23 | Conversion : show line 3 in the form | +271,870 | 14,108 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-23 | Conversion : show line 4 in the form Series A Non-Voting Convertible Preferred Stock | −4,928 | 0 | D |
| 2022-08-23 | Conversion : show line 5 in the form Series A Non-Voting Convertible Preferred Stock | −27,187 | 0 | I |
| 2023-08-23 | Grant or award : show line 6 in the form Stock Options (Right to Buy) | +2,000 | 2,000 | D |
Loading xslF345X05/tm2324788-8_4seq1.xml…